HbA1c is the world’s most widely used test for diagnosing type 2 diabetes. New evidence shows that G6PD deficiency and other genetic variants are systematically distorting its results for Black and ...

BlogWhat the UK Biobank data exposure should mean for the Health Data Research ServiceWednesday May 13, 2026Potential fallout from the recent UK Biobank data exposure - and similar cases - highlights ...

In this blog, I will delve into some of the growing acceptance in healthcare to innovative approaches in various countries, and how a database will facilitate analysis and interpretation for all. The ...

The Wellcome Trust recently announced that they are funding a research programme to investigate synthetic human genomes, and Laura Blackburn, PHG Foundation’s Head of Science, had the opportunity to ...

Until the coronavirus pandemic took hold, it seemed that at least every other headline about healthcare innovations was related to machine learning or other forms of artificial intelligence (AI) – ...

The European Health Data Space Regulation has arrived but will its mandatory sharing requirement be its tour de force or Achilles’ heel? The Regulation amounts to an ambitious and laudable step ...

The virtual launch this month of the Africa Pathogen Genomics Initiative (Africa PGI) marked a ground-breaking initiative to tackle infectious disease in Africa. Led by the African Union Commission ...

We are getting closer to a world where the debilitating pain and complications of sickle cell disease are a thing of the past. For the 17,500 people in the UK living with this genetic condition, this ...

A recent consultation by the UK Medicines and Healthcare products Regulatory Agency (MHRA) indicates a welcome new direction for public and patient involvement (PPI). The MHRA proposed new five-year ...

Quantum computing, a type of quantum technology, is poised to address pressing challenges in the healthcare sector. For example, while the average cost of the drug development pipeline has tripled ...

It is no secret that the AI regulatory landscape has experienced monumental shifts in the last six months. Rhetoric that views regulation as a barrier to AI innovation and the cross-sectoral ...

Following the successful completion of the NHS national pilot in April 2025, the highly anticipated first results assessing CYP2C19 genetic testing to guide clopidogrel use in ischaemic stroke and TIA ...